Aflac or MetLife: Which Insurance Dividend Wins for Long-Term Income?

Published November 16, 2026, 8:47am ET · 3 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Aflac logo sculpture with duck mascot standing on a stone base at the entrance
Aug 2020 - Aflac WWHQ, Columbus, GA. Photo by John David Helms [email protected] © Aflac WWHQ (CC BY-SA 4.0) by Jhelmsaflac

Aflac (NYSE:AFL | AFL Price Prediction) or MetLife (NYSE:MET): which insurance dividend holds up better on the measures that matter for retirement income? Both insurers are close in size, with market caps of $63.12 billion and $64.51 billion. In 2026, though, their income stories moved in opposite directions.

AFL price target

MET price target

Here is how both companies make money. An insurer takes in premiums now and pays claims later. Until then, it invests that pool of cash, called the float, mostly in bonds. Profit comes from two places: underwriting, where premiums exceed claims and costs, and investment income on the float.

Aflac’s float is anchored in Japan, where it is the top provider of cancer and medical insurance, so the yen drives its reported results. MetLife spreads its money across group benefits, pension risk transfer, Asia, Latin America, and an asset manager managing $748.1 billion. That mix makes interest rates and markets its main swing factors. Its portfolio yielded 5.02% annualized in Q2 2026.

Dividend Track Record: Aflac Wins Easily

Aflac reached 44 consecutive years of dividend increases in 2026, making it a Dividend Aristocrat. On November 12, 2026, it declared a first-quarter 2027 dividend of $0.64, up from $0.61. That is a 4.9% raise. In 2021, the quarterly payout was $0.33, so the dividend has grown about 94% since then. Management treats the record as a priority: “We treasure our 2026 milestone of 44 consecutive years of dividend increases.”

MetLife also raises its dividend every year, but in smaller steps. Its quarterly dividend went from $0.46 in early 2021 to $0.5925, a gain of about 29%. Its 2026 raise was roughly 4.4%, and it has no Aristocrat-length run.

Yield and Payout Coverage: MetLife Takes It

At $102.65, MetLife’s $2.37 forward dividend yields about 2.3%. Aflac’s $2.56 at $127.61 yields about 2.0%. Measured against 2025 EPS of $8.84[1] and $7.49[2], MetLife’s forward dividend takes about 27% of earnings. Aflac’s takes about 34%.

Both companies also return capital through buybacks. MetLife returned nearly $4.4 billion[1] in 2025. Aflac bought back $3.5 billion[2] in shares in 2025, and in Q3 2026 it returned $1.1 billion ($804 million in buybacks, $305 million in dividends). MetLife wins this round because it pays a higher yield while using a smaller share of its earnings.

Earnings Momentum: MetLife by a Wide Margin

MetLife has beaten estimates for four consecutive quarters. In Q2 2026, adjusted EPS of $2.43[3] exceeded the $2.29 consensus and rose 20% year over year. Group Benefits earnings climbed 25% to $503 million[3]. The CEO, Michel Khalaf, said: “Our New Frontier strategy is working. Disciplined execution is driving balanced growth and generating attractive returns, with adjusted return on equity at 17 percent year-to-date.”[3]

Aflac has missed expectations for four straight quarters. Its Q3 GAAP EPS of $0.61 fell from $1.1 billion due to investment losses tied to portfolio adjustments. Japan pretax adjusted earnings fell 15.2% in yen. A weaker yen at 158.49 vs. 147.68 per dollar reduced EPS by $0.03. The U.S. business was the bright spot, with pretax adjusted earnings up 31.5% to $493 million.


The stock prices reflect the gap. MetLife is up 33.58% year to date, compared with 17.56% for Aflac. Over ten years, the order passes: Aflac is up 341.24% and MetLife 192.26%.

AFL analyst ratings

MET analyst ratings

Verdict: MetLife Leads on Current Income

MetLife wins two of the three rounds on current income measures. It pays the higher yield, uses less of its earnings to cover the dividend, and has earnings growing at a 20% clip. Its diversified business also spreads its currency exposure across several regions.

Aflac leads on dividend growth, with the faster-growing payout of the two and a 44-year run. Its longer record gives it room to work through the Japan slowdown. In the near term, watch whether Aflac’s Japan earnings stabilize and whether MetLife’s spring dividend increase exceeds its recent raises.

Contact [email protected] for any questions or corrections.

Chris Lange

Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.

His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.

When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.

All articles →

Sources

  1. MetLife Form 8-K (Q4 FY2025)U.S. Securities and Exchange Commission
  2. Aflac Form 8-K (Q4 FY2025)U.S. Securities and Exchange Commission
  3. MetLife Form 8-K (Q2 FY2026)U.S. Securities and Exchange Commission